News
Rory Johnson and members of the TBDO participated in the ‘Personalized Medicines & Biomarkers 2015’ conference in London
Rory Johnson, Ramon y Cajal fellow at the Computational Biology of RNA Processing laboratory, together with members of the TBDO team, participated in the “Personalized Medicines & Biomarkers 2015” conference, held in London UK on 2nd and 3rd December 2015. The participation to this event, organized within the frame of the Science to Business (S2B) Concept Challenge (2015 Edition) award, was a great opportunity to learn from, and network with, leaders from biotech and pharma in the field of biomarker discovery and development. We expect that this valuable experience will help Rory promoting his entrepreneurial project, focused on non-invasive RNA treatment-decision biomarkers for chronic lymphocytic leukemia.
The TBDO participated in the BioFIT event in Strasbourg
BioFIT is the leading partnering event in Europe for open innovation, technology transfer and collaborative research in the field of Life Sciences: another great opportunity for partnering, networking and promoting CRG technologies.
The TBDO will participate in the Bio-Europe 2015 in Munich
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies: a great opportunity for partnering, networking and promoting CRG technologies.
CRG Proof of Concept: Commercialization Gap Fund (CGF)
Deadline: 27/11/2015
Please send your Full Proposal (max. 10 pages) under the following schemes:
- MIDI - Up to 6 months and 35 kEUR
- MAXI - Up to 12 months and 75 kEUR
Xavier Gallego joins the Entrepreneur-In-Residence Program
Health & Bio Team Dating
On 3 December 2015, Banc Sabadell, Biocat, CataloniaBio and the Bosch i Gimpera Foundation are holding Health & Bio Team Dating, an event where scientist and business professionals can talk about their projects and themselves with the aim of building a balanced team to lead successful start-up in the life sciences.
Victor LLorente joins the Entrepreneur-In-Residence Program
Victor will collaborate with the TBDO team at CRG, looking for business opportunities based on innovative technologies in the software and medical sectors.
CRG Proof of Concept: Commercialization Gap Fund (CGF)
Deadline: 11/10/2015 (Approaching!)
Please send your application (max. 2 pages) under the following schemes:
- MIDI - Up to 6 months and 35 kEUR
- MAXI - Up to 12 months and 75 kEUR
AstraZeneca embraces crowdsourcing in cancer R&D
UK pharma company jumps on the open access R&D bandwagon, offering access to data on over 50 of its drugs, with the aim of inspiring new combination therapies for cancer.
- « first
- ‹ previous
- 1
- 2
- 3
- 4